Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Rare Tumors is Scopus-indexed (Q3, CiteScore 1.6), WoS ESCI, DOAJ. Published by Page Press Publications.
Checked against the index lists dated .
ISSN 2036-3605Verify ISSN ↗2036-3613Verify ISSN ↗
Publisher: Page Press Publications
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 306 / 428 | 28th | Q3 |
| Histology | 47 / 62 | 25th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q3, CiteScore 1.6.
Rare Tumors is Q3 in Oncology (rank 306 of 428) and Q3 in Histology (rank 47 of 62), by CiteScore 2025.
Rare Tumors is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.6, which places it in quartile Q3 at the 28th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.370, quartile Q3, with an H-index of 24.
The publisher lists an article processing charge of about US$2,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Rare Tumors is published by Page Press Publications. Its print ISSN is 2036-3605 and its online ISSN is 2036-3613.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Rare Tumors has an h-index of 32 and a 2-year mean of 1.3 citations per paper (OpenAlex). Its Scopus CiteScore is 1.6, quartile Q3. On 2-year citations it ranks #261 of 424 Scopus journals in Oncology.
Rare Tumors published 15 papers in 2025; its busiest recent year was 2021 with 38. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2023–2026), authors are most often from United States (20.9%), Pakistan (9.8%) and India (7.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.